{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:35:46Z","timestamp":1787160946122,"version":"build-2736575974"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T00:00:00Z","timestamp":1722384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Rezum alleviates lower urinary tract symptoms secondary to benign prostatic hyperplasia (BPH) while preserving sexual function, but long-term sexual function outcomes are lacking in patients with baseline erectile dysfunction (ED).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>The study sought to analyze 4\u00a0years of real-world sexual function outcomes of Rezum using the International Index of Erectile Function (IIEF) questionnaire, stratified by baseline ED status.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Participants included multiethnic Rezum-treated patients from a single outpatient office. IIEF domains and BPH medication usage were compared at baseline and 6, 12, and 48\u00a0months using t tests, Mann-Whitney U tests, chi-square tests, and Wilcoxon signed rank tests.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes<\/jats:title>\n                    <jats:p>Primary outcomes over 4\u00a0years included the IIEF functional domains (erectile function [EF], orgasmic function [OF], sexual desire [SD], intercourse satisfaction [IS], overall satisfaction [OS]) and BPH medication usage.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 91 patients were included: 40 (44%) in the ED cohort and 51 (56%) in the no ED cohort. History of diabetes was more prevalent in the ED cohort (35% vs 15.7%; P\u2009=\u2009.048). Baseline scores in the EF, OF, IS, and OS domains were lower in the ED cohort. Compared with baseline, there were no significant changes in any IIEF domains in either cohort at 6\u00a0months. At 12\u00a0months, the ED cohort had significant percent decreases in OF (\u221225%; P\u2009=\u2009.02), SD (\u221222.2%; P\u2009=\u2009.04), and OS (\u221233.3%; P\u2009=\u2009.004); the no ED cohort had a significant percent increase in EF (5%; P\u2009=\u2009.04). At 48\u00a0months, the no ED cohort had no significant changes in any IIEF domains, while the ED cohort had significant percent increases in EF (30%; P\u2009=\u2009.01), SD (22.5%; P\u2009=\u2009.02), IS (20%; P\u2009=\u2009.01), and OS (58.3%; P\u2009=\u2009.008). Both cohorts significantly discontinued BPH medications at all follow-ups. At 48\u00a0months, there were no cases of de novo ED in the no ED cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical Implications<\/jats:title>\n                    <jats:p>As modern BPH therapies continue to demonstrate efficacy in alleviating lower urinary tract symptoms, the preservation or improvement of sexual function emerges as an increasingly important consideration for patients, with our study suggesting Rezum as a compelling option.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Strengths and Limitations<\/jats:title>\n                    <jats:p>Our study has the strength of long-term Rezum outcomes in an ethnically diverse patient population, stratified by the presence of baseline ED, but is limited by retrospective design, single-center nature, and small sample sizes at long-term follow-ups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Rezum preserved long-term sexual function in patients without baseline ED and improved sexual function in those with baseline ED; however, individuals with ED may experience temporary decreases in sexual function at 12\u00a0months.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jsxmed\/qdae087","type":"journal-article","created":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T18:28:16Z","timestamp":1720722496000},"page":"777-786","source":"Crossref","is-referenced-by-count":9,"title":["Four years of real-world sexual function outcomes after Rezum therapy in men with and without baseline erectile dysfunction"],"prefix":"10.1093","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-7826-7942","authenticated-orcid":false,"given":"Noah","family":"Hawks-Ladds","sequence":"first","affiliation":[{"name":"Albert Einstein College of Medicine , Bronx, NY 10461 , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Cook","sequence":"additional","affiliation":[{"name":"Albert Einstein College of Medicine , Bronx, NY 10461 , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8490-2260","authenticated-orcid":false,"given":"Mustufa","family":"Babar","sequence":"additional","affiliation":[{"name":"Albert Einstein College of Medicine , Bronx, NY 10461 , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Zhu","sequence":"additional","affiliation":[{"name":"Albert Einstein College of Medicine , Bronx, NY 10461 , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4085-1665","authenticated-orcid":false,"given":"Alison","family":"Schulz","sequence":"additional","affiliation":[{"name":"Albert Einstein College of Medicine , Bronx, NY 10461 , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Loloi","sequence":"additional","affiliation":[{"name":"Department of Urology, Montefiore Medical Center , Bronx, NY 10467 , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaki","family":"Masoud","sequence":"additional","affiliation":[{"name":"NYU Grossman Long Island School of Medicine Department of Medicine, , Mineola, NY 11501 , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaskirat","family":"Singh","sequence":"additional","affiliation":[{"name":"DSS Urology , Queens Village, NY 11427 , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"Jamil","sequence":"additional","affiliation":[{"name":"School of Public Health, St. Luke International University , Tokyo 104-8560 , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahman","family":"Sayed","sequence":"additional","affiliation":[{"name":"Albert Einstein College of Medicine , Bronx, NY 10461 , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Ines","sequence":"additional","affiliation":[{"name":"DSS Urology , Queens Village, NY 11427 , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Ciatto","sequence":"additional","affiliation":[{"name":"DSS Urology , Queens Village, NY 11427 , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,7,31]]},"reference":[{"key":"2024090406282872000_ref1","author":"Ng","year":"2024"},{"key":"2024090406282872000_ref2","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ijsu.2015.11.043","article-title":"Assessment and management of male lower urinary tract symptoms (LUTS)","volume":"25","author":"Abdelmoteleb","year":"2016","journal-title":"Int J Surg"},{"issue":"6","key":"2024090406282872000_ref3","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.eururo.2004.12.013","article-title":"Sexual dysfunction and lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH)","volume":"47","author":"Rosen","year":"2005","journal-title":"Eur Urol"},{"issue":"4","key":"2024090406282872000_ref4","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s11255-008-9386-z","article-title":"The relationship between lower urinary tract symptoms (LUTS), diagnostic indicators of benign prostatic hyperplasia (BPH), and erectile dysfunction in patients with moderate to severely symptomatic BPH","volume":"40","author":"Ozayar","year":"2008","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"2024090406282872000_ref5","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/ijcp.12044","article-title":"Coexisting lower urinary tract symptoms and erectile dysfunction: a systematic review of epidemiological data","volume":"67","author":"Seftel","year":"2013","journal-title":"Int J Clin Pract"},{"issue":"3","key":"2024090406282872000_ref6","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.urology.2008.05.034","article-title":"Association of sexual dysfunction with lower urinary tract symptoms of BPH and BPH medical therapies: results from the BPH registry","volume":"73","author":"Rosen","year":"2009","journal-title":"Urology"},{"issue":"1","key":"2024090406282872000_ref7","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12894-015-0090-x","article-title":"Patient's adherence on pharmacological therapy for benign prostatic hyperplasia (BPH)-associated lower urinary tract symptoms (LUTS) is different: is combination therapy better than monotherapy?","volume":"15","author":"Cindolo","year":"2015","journal-title":"BMC Urol"},{"issue":"1","key":"2024090406282872000_ref8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/13685538.2017.1367922","article-title":"Administration of daily 5\u2009mg tadalafil improves endothelial function in patients with benign prostatic hyperplasia","volume":"21","author":"Amano","year":"2018","journal-title":"Aging Male"},{"issue":"4","key":"2024090406282872000_ref9","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1308\/rcsann.2018.0054","article-title":"The changing practice of transurethral resection of the prostate","volume":"100","author":"Young","year":"2018","journal-title":"Ann R Coll Surg Engl"},{"issue":"7","key":"2024090406282872000_ref10","first-page":"CD013656","article-title":"Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network meta-analysis","volume":"7","author":"Franco","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"2024090406282872000_ref11","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1177\/1756287218793084","article-title":"Rezum: a new transurethral water vapour therapy for benign prostatic hyperplasia","volume":"10","author":"Westwood","year":"2018","journal-title":"Ther Adv Urol"},{"issue":"1","key":"2024090406282872000_ref12","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/s41391-023-00703-0","article-title":"Real-world four-year functional and surgical outcomes of Rezum therapy in younger versus elderly men","volume":"27","author":"Zhu","year":"2023","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"3","key":"2024090406282872000_ref13","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/luts.12435","article-title":"Emerging outcomes of water vapor thermal therapy (Rezum) in a broad range of patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia: a systematic review","volume":"14","author":"Babar","year":"2022","journal-title":"Low Urin Tract Symptoms"},{"issue":"6","key":"2024090406282872000_ref14","doi-asserted-by":"crossref","first-page":"100454","DOI":"10.1016\/j.esxm.2021.100454","article-title":"Preservation of sexual function 5 years after water vapor thermal therapy for benign prostatic hyperplasia","volume":"9","author":"McVary","year":"2021","journal-title":"Sex Med"},{"issue":"3","key":"2024090406282872000_ref15","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/JU.0000000000001778","article-title":"Final 5-year outcomes of the Multicenter randomized sham-controlled trial of a water vapor thermal therapy for treatment of moderate to severe lower urinary tract symptoms secondary to benign prostatic hyperplasia","volume":"206","author":"McVary","year":"2021","journal-title":"J Urol"},{"issue":"1","key":"2024090406282872000_ref16","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/UPJ.0000000000000061","article-title":"Convective radio frequency thermal therapy for treatment of benign prostatic hyperplasia: single office experience with 255 patients over 4 years","volume":"7","author":"Mooney","year":"2020","journal-title":"Urol Pract"},{"issue":"4","key":"2024090406282872000_ref17","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/sj.ijir.3900859","article-title":"The use of the simplified international index of erectile function (IIEF-5) as a diagnostic tool to study the prevalence of erectile dysfunction","volume":"14","author":"Rhoden","year":"2002","journal-title":"Int J Impot Res"},{"issue":"7","key":"2024090406282872000_ref18","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/pros.24508","article-title":"Rezum water vapor therapy for patients with mild, moderate, or severe lower urinary tract symptoms: a retrospective study in a multiethnic population","volume":"83","author":"Babar","year":"2023","journal-title":"Prostate"},{"issue":"13","key":"2024090406282872000_ref19","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1002\/pros.24191","article-title":"Real-world evidence with the Rez\u016bm system: a retrospective study and comparative analysis on the efficacy and safety of 12 month outcomes across a broad range of prostate volumes","volume":"81","author":"Ines","year":"2021","journal-title":"Prostate"},{"key":"2024090406282872000_ref20","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11934-020-01018-6","article-title":"What is new with Rez\u016bm water vapor thermal therapy for LUTS\/BPH?","volume":"22(1)","author":"Doppalapudi","year":"2021","journal-title":"Curr Urol Rep"},{"issue":"9","key":"2024090406282872000_ref21","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1007\/s11255-021-02878-8","article-title":"Rezum: a novel minimally invasive treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia. A review article","volume":"53","author":"Higazy","year":"2021","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"2024090406282872000_ref22","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/smrj.3","article-title":"Side effects of 5-alpha reductase inhibitors: a comprehensive review","volume":"1","author":"Trost","year":"2013","journal-title":"Sex Med Rev"},{"issue":"3","key":"2024090406282872000_ref23","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/13685538.2016.1195361","article-title":"Impact of combination therapy 5-alpha reductase inhibitors (5-ARI) plus alpha-blockers (AB) on erectile dysfunction and decrease of libido in patients with LUTS\/BPH: a systematic review with meta-analysis","volume":"19","author":"Favilla","year":"2016","journal-title":"Aging Male"},{"issue":"20","key":"2024090406282872000_ref24","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.eursup.2006.08.012","article-title":"Safety and tolerability of treatment for BPH","volume":"5","author":"Montorsi","year":"2006","journal-title":"Eur Urol Suppl"},{"issue":"4","key":"2024090406282872000_ref25","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/00365590902930824","article-title":"Erectile dysfunction after prostatectomy: an evaluation of the risk factors","volume":"43","author":"Soleimani","year":"2009","journal-title":"Scand J Urol Nephrol"},{"issue":"3","key":"2024090406282872000_ref26","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.purol.2014.12.003","article-title":"Negative effects on sexual function of medications for the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia","volume":"25","author":"Descazeaud","year":"2015","journal-title":"Prog Urol"},{"issue":"10","key":"2024090406282872000_ref27","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s11934-014-0441-2","article-title":"Impact of alpha blockers, 5-alpha reductase inhibitors and combination therapy on sexual function","volume":"15","author":"Welliver","year":"2014","journal-title":"Curr Urol Rep"},{"issue":"6","key":"2024090406282872000_ref28","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/j.juro.2013.12.014","article-title":"Change in sexual function in men with lower urinary tract symptoms\/benign prostatic hyperplasia associated with long-term treatment with doxazosin, finasteride and combined therapy","volume":"191","author":"Fwu","year":"2014","journal-title":"J Urol"},{"issue":"3","key":"2024090406282872000_ref29","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2190\/NHV6-3DYB-X51G-4BVM","article-title":"Psychogenic erectile dysfunction","volume":"33","author":"Bodie","year":"2003","journal-title":"Int J Psychiatry Med"},{"issue":"2","key":"2024090406282872000_ref30","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0094-0143(05)70137-3","article-title":"Psychogenic erectile dysfunction. Classification and management","volume":"28","author":"Rosen","year":"2001","journal-title":"Urol Clin N Am"},{"issue":"4_part_1","key":"2024090406282872000_ref31","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1111\/j.1743-6109.2009.01656.x","article-title":"Psychological determinants of erectile dysfunction: testing a cognitive\u2013emotional model","volume":"7","author":"Nobre","year":"2010","journal-title":"J Sex Med"},{"issue":"5","key":"2024090406282872000_ref32","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1007\/s10508-008-9450-x","article-title":"Cognitive schemas associated with negative sexual events: a comparison of men and women with and without sexual dysfunction","volume":"38","author":"Nobre","year":"2009","journal-title":"Arch Sex Behav"},{"issue":"10","key":"2024090406282872000_ref33","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1089\/end.2013.0216","article-title":"Kumar A, Vasudeva P, Kumar N, Nanda B, Jha SK, Mohanty N. A prospective randomized comparative study of monopolar and bipolar transurethral resection of the prostate and photoselective vaporization of the prostate in patients who present with benign prostatic obstruction: a single center experience","volume":"27","year":"2013","journal-title":"J Endourol"},{"key":"2024090406282872000_ref34","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11934-018-0813-0","article-title":"A review of male sexual health and dysfunction following surgical treatment for benign prostatic hyperplasia and lower urinary tract symptoms","volume":"19","author":"Borchert","year":"2018","journal-title":"Curr Urol Rep"},{"issue":"3","key":"2024090406282872000_ref35","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1046\/j.1464-410x.1999.00908.x","article-title":"Is transurethral resection of the prostate still justified?","volume":"83","author":"Madersbacher","year":"1999","journal-title":"BJU Int"},{"issue":"4","key":"2024090406282872000_ref36","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/S0022-5347(05)67142-X","article-title":"Impact of interventional therapy for benign prostatic hyperplasia on quality of life and sexual function: a prospective study","volume":"164","author":"Arai","year":"2000","journal-title":"J Urol"},{"issue":"5","key":"2024090406282872000_ref37","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1464-410X.2011.10396.x","article-title":"TURP and sex: patient and partner prospective 12 years follow-up study","volume":"109","author":"Mishriki","year":"2012","journal-title":"BJU Int"},{"issue":"7345","key":"2024090406282872000_ref38","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1136\/bmj.324.7345.1059","article-title":"Sexual dysfunction in men after treatment for lower urinary tract symptoms: evidence from randomised controlled trial","volume":"324","author":"Brookes","year":"2002","journal-title":"BMJ"},{"issue":"5","key":"2024090406282872000_ref39","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1097\/01.ju.0000140501.68841.a1","article-title":"Holmium laser enucleation versus transurethral resection of the prostate: results from a 2-center, prospective, randomized trial In patients with obstructive benign prostatic hyperplasia","volume":"172","author":"Montorsi","year":"2004","journal-title":"J Urol"},{"issue":"2","key":"2024090406282872000_ref40","doi-asserted-by":"crossref","first-page":"148","DOI":"10.4111\/icu.20200392","article-title":"A state-of-art review on the preservation of sexual function among various minimally invasive surgical treatments for benign prostatic hyperplasia: impact on erectile and ejaculatory domains","volume":"62","author":"Ng","year":"2021","journal-title":"Investig Clin Urol"},{"issue":"12","key":"2024090406282872000_ref41","doi-asserted-by":"crossref","DOI":"10.1007\/s11934-020-01012-y","article-title":"A systematic review of reported ejaculatory dysfunction in clinical trials evaluating minimally invasive treatment modalities for BPH","volume":"21","author":"Lokeshwar","year":"2020","journal-title":"Curr Urol Rep"},{"issue":"4","key":"2024090406282872000_ref42","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1089\/end.2020.0739","article-title":"An indirect comparison of newer minimally invasive treatments for benign prostatic hyperplasia: a network meta-analysis model","volume":"35","year":"2021","journal-title":"J Endourol"},{"issue":"6","key":"2024090406282872000_ref43","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.eururo.2014.06.017","article-title":"A systematic review and meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic obstruction: an update","volume":"67","author":"Cornu","year":"2015","journal-title":"Eur Urol"},{"issue":"1","key":"2024090406282872000_ref44","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.sxmr.2016.05.006","article-title":"Benign prostatic hyperplasia treatment options and their effects on sexual function","volume":"5","author":"Voznesensky","year":"2017","journal-title":"Sex Med Rev"},{"issue":"5","key":"2024090406282872000_ref45","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41443-019-0140-0","article-title":"The impact of surgery for lower urinary tract symptoms\/benign prostatic enlargement on both erectile and ejaculatory function: a systematic review","volume":"31","author":"Verze","year":"2019","journal-title":"Int J Impot Res"},{"issue":"6","key":"2024090406282872000_ref46","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/j.juro.2013.05.116","article-title":"The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the L.I.F.T","volume":"190","author":"Roehrborn","year":"2013","journal-title":"study. J Urol"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/21\/9\/777\/59002071\/qdae087.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/21\/9\/777\/59002071\/qdae087.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T19:45:31Z","timestamp":1725479131000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/21\/9\/777\/7724729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,31]]},"references-count":46,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,7,31]]},"published-print":{"date-parts":[[2024,9,3]]}},"URL":"https:\/\/doi.org\/10.1093\/jsxmed\/qdae087","relation":{},"ISSN":["1743-6095","1743-6109"],"issn-type":[{"value":"1743-6095","type":"print"},{"value":"1743-6109","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,9]]},"published":{"date-parts":[[2024,7,31]]}}}